GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Fos | decreases expression | EXP | | 6480464 | CTD | Methylphenidate results in decreased expression of FOS protein | PMID:15916815 | Fos | increases expression | EXP | | 6480464 | CTD | Methylphenidate results in increased expression of FOS mRNA | PMID:19931852 PMID:21753012 | Fos | multiple interactions | EXP | | 6480464 | CTD | [Fluoxetine co-treated with Methylphenidate] results in increased expression of FOS mRNA; Fluoxetine promotes the reaction [Methylphenidate results in increased expression of FOS mRNA] | PMID:19931852 PMID:21753012 | Fos | increases expression | ISO | Fos (Mus musculus) | 6480464 | CTD | Methylphenidate results in increased expression of FOS protein | PMID:12699766 | Fos | increases expression | ISO | FOS (Homo sapiens) | 6480464 | CTD | Methylphenidate results in increased expression of FOS mRNA; Methylphenidate results in increased expression of FOS protein | PMID:12112414 | Fos | multiple interactions | ISO | Fos (Mus musculus) | 6480464 | CTD | SLC6A3 protein affects the reaction [Methylphenidate results in increased expression of FOS protein] | PMID:12699766 | Fos | multiple interactions | ISO | FOS (Homo sapiens) | 6480464 | CTD | [Methylphenidate co-treated with SLC6A3 protein] results in increased expression of FOS protein; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein] | PMID:12112414 | |
Go Back to source page | Continue to Ontology report |